Attunement

Founded in 2023 and part of the Y Combinator W24 batch, Attunement operates within the healthcare industry, focusing on therapeutics for behavioral health. The company, with a team of two, has developed a patient monitoring and treatment recommendation platform designed to enhance the management of mental health treatments. Attunement’s technology facilitates continuous behavioral health tracking, aiming to remove the uncertainties often associated with mental health treatment progress. Additionally, the company offers a beta program specifically for physicians or behavioral health professionals, encouraging them to integrate this new technology into their practices. Although currently at an early stage of development, Attunement serves an unspecified region and is actively seeking to expand its impact in the field of digital therapeutics.